Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will examine a Ready to Drink (RTD) supplement.
This study will examine the short-term (7 days) characteristics of ingesting a Ready to Drink (RTD) supplement immediately prior to exercise on the blood, heart rate, blood pressure and self-reported side effects.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| RTD | Experimental | 2.1 g. beta alanine, 1.3 g arginine nitrate, 200 mg caffeine, 65 mg niacin, 325 mcg folic acid, 45 mcg vitamin B12 |
|
| Placebo | Placebo Comparator | dextrose and non-caloric flavoring |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| RTD | Dietary Supplement | Ready to Drink Supplement |
| |
| Placebo |
| Measure | Description | Time Frame |
|---|---|---|
| The effects of ingesting an RTD immediately prior to exercise on the blood | 7 days | |
| The effects of ingesting an RTD immediately prior to exercise on heart rate | 7 days | |
| The effects of ingesting an RTD immediately prior to exercise on blood pressure | 7 days |
| Measure | Description | Time Frame |
|---|---|---|
| The effects of ingesting an RTD immediately prior to exercise on self-reported side effects | 7 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Richard B Kreider, PhD | Texas A&M University | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dietary Supplement |
Placebo |
|